Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF)

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 4, 2008, Pages

  Ren, YiLin ^a   D'Ambrosio, Martin A ^a   Wang, Hong ^a   Liu, Ruisheng ^a   Garvin, Jeffrey L ^a   Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Afferent arteriole; Biliverdin; Carbon monoxide; Macula densa

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; HEME OXYGENASE; MESOPORPHYRIN; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; STANNOUS MESOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEEDBACK SYSTEM; IN VITRO STUDY; KIDNEY PERFUSION; KIDNEY TUBULOGLOMERULAR FEEDBACK; MALE; METABOLITE; NEGATIVE FEEDBACK; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 57049152966     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90243.2008     Document Type: Article

References (59)

1. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127, 2008.
2. Abraham NG, Lin JH, Laniado Schwartzman M, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem 20: 543-558, 1988.
3. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, Ohno M. Heme-oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats. Possible role in renoprotection. Hypertension 35: 800-806, 2000.
4. Appleton SD, Chretien ML, McLaughlin BE, Vreman HJ, Stevenson DK, Brien JF, Nakatsu K, Maurice DH, Marks GS. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos 27: 1214-1219, 1999.
5. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
6. Bell PD, Lapointe JY, Peti-Peterdi J. Macula densa cell signaling. Annu Rev Physiol 65: 32.1-32.20, 2003.
7. Botros FT, Laniado-Schwartzman M, Stier CT Jr, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 68: 2745-2755, 2005.
8. Botros FT, Navar LG. Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles. Am J Physiol Heart Circ Physiol 291: H2772-H2778, 2006.
9. Brem AS, Cashore WJ, Pacholski M, Tetreault J, Lawler RG. Effects of bilirubin on transepithelial transport of sodium, water, and urea. Kidney Int 27: 51-57, 1985.
10. Broberger U, Aperia A. Renal function in infants with hyperbilirubinemia. Acta Paediatr Scand 68: 75-79, 1979.
11. da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos E, Abraham NG. Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 59: 1448-1457, 2001.
12. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 96: 2445-2450, 1999.
13. Finestone H, Fechner C, Levy M. Effects of bile and bile salt infusions on renal function in dogs. Can J Physiol Pharmacol 62: 762-768, 1984.
14. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, Motterlini R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142: 453-460, 2004.
15. Hill-Kapturczak N, Chang SH, Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 21: 307-321, 2002.
16. Hu Y, Ma N, Yang M, Semba R. Expression and distribution of heme oxygenase-2 mRNA and protein in rat kidney. J Histochem Cytochem 46: 249-256, 1998.
17. Ito S, Carretero OA. An in vitro approach to the study of macula densa-mediated glomerular hemodynamics. Kidney Int 38: 1206-1210, 1990.
18. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 92: 1093-1098, 1993.
19. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, Nasjletti A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107: 1163-1171, 2001.
20. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol Regul Integr Comp Physiol 276: R1087-R1094, 1999.
21. Li N, Yi F, Dos Santos EA, Donley DK, Li PL. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension 49: 148-154, 2007.
22. Li P, Jiang H, Yang L, Quan S, Dinocca S, Rodriguez F, Abraham NG, Nasjletti A. Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation. Am J Physiol Renal Physiol 287: F914-F920, 2004.
23. Liu R, Carretero OA, Ren Y, Garvin JL. Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback. Kidney Int 67: 1837-1843, 2004.
24. Lutton JD, Abraham NG, Drummond GS, Levere RD, Kappas A. Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow. Proc Natl Acad Sci USA 94: 1432-1436, 1997.
25. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
26. Maines MD, Ibrahim NG, Kappas A. Solubilization and partial purification of heme oxygenase from rat liver. J Biol Chem 252: 5900-5903, 1977.
27. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 12: 185-188, 1991.
28. Martinez-Maldonado M, Suki WN, Schenker S. Nature of the urinary concentrating defect in the Gunn strain of rat. Am J Physiol 216: 1386-1391, 1969.
29. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13: 1225-1233, 1994.
30. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92: 1475-1479, 1995.
31. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24, 2002.
32. Motterlini R, Foresti R, Green CJ. Studies on the development of carbon monoxide-releasing molecules: potential applications for the treatment of cardiovascular dysfunction. In: Carbon Monoxide and Cardiovascular Functions, edited by Wang R. Boca Raton, FL: CRC, 2002, p. 249-271.
33. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 9: 2525-2539, 2003.
34. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156: 1527-1535, 2000.
35. O'Donaughy TL, Walker BR. Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats. Am J Physiol Heart Circ Physiol 279: H2908-H2915, 2000.
36. Ortiz PA, Garvin JL. NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase. Hypertension 37: 467-471, 2001.
37. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 4: 309-319, 2002.
38. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
39. Quan S, Yang L, Shnouda S, Schwartzman ML, Nasjletti A, Goodman AI, Abraham NG. Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int 65: 1628-1639, 2004.
40. Ren Y, Arima S, Carretero OA, Ito S. Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int 61: 169-176, 2002.
41. Ren Y, Carretero OA, Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension 39: 624-628, 2002.
42. Ren Y, Carretero OA, Ito S. Influence of NaCl concentration at the macula densa on angiotensin II-induced constriction of the afferent arteriole. Hypertension 27: 649-652, 1996.
43. Ren Y, Garvin JL, Carretero OA. Role of macula densa nitric oxide and cGMP in the regulation of tubuloglomerular feedback. Kidney Int 58: 2053-2060, 2000.
44. Ren Y, Garvin JL, Ito S, Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 60: 1676-1683, 2001.
45. Robertson P Jr, Fridovich I. A reaction of the superoxide radical with tetrapyrroles. Arch Biochem Biophys 213: 353-357, 1982.
46. Rodriguez F, Kemp R, Balazy M, Nasjletti A. Effects of exogenous heme on renal function. Role of heme oxygenase and cyclooxygenase. Hypertension 42: 680-684, 2003.
47. Rodriguez F, Lamon BD, Gong W, Kemp R, Nasjletti A. Nitric oxide synthesis inhibition promotes renal production of carbon monoxide. Hypertension 43: 347-351, 2004.
48. Schnermann J, Briggs J. Concentration-dependent sodium chloride transport as the signal in feedback control of glomerular filtration rate. Kidney Int 22, Suppl 12: S-82-S-89, 1982.
49. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726-F736, 2000.
50. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
51. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol Renal Physiol 277: F882-F889, 1999.
52. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 170: 1820-1830, 2007.
53. Vogt BA, Shanley TP, Croatt A, Alam J, Johnson KJ, Nath KA. Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 98: 2139-2145, 1996.
54. Wang H, Carretero OA, Garvin JL. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension 39: 662-666, 2002.
55. Wang R, Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272: 8222-8226, 1997.
56. Welch WJ, Wilcox CS. What is brain nitric oxide synthase doing in the kidney? Curr Opin Nephrol Hypertens 11: 109-115, 2002.
57. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585-630, 2005.
58. Zhang F, Kaide JI, Wei Y, Jiang H, Yu C, Balazy M, Abraham NG, Wang W, Nasjletti A. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 281: H350-H358, 2001.
59. Zou AP, Billington H, Su N, Cowley AW Jr. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 35: 342-347, 2000.